Alpibectir (BVL-GSK098) is a transcription factor inhibitor. Alpibectir acts on VirS to increase Ethionamide (HY-B0276) bioactivation via the alternative MymA pathway. Alpibectir augments Ethionamide activity and overcomes ethionamide resistance from EthA mutations. Alpibectir can be used for the research of tuberculosis (tb)[1].
Molecular Weight:
332.24
Purity:
99.81
CAS Number:
[2285440-39-1]
Formula:
C12H14F6N2O2
Target:
Bacterial
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted